Glycoprotein iib/iiia antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/58 (2006.01) A61K 31/335 (2006.01) A61K 31/395 (2006.01) A61K 31/675 (2006.01) C07C 257/18 (2006.01) C07C 271/64 (2006.01) C07D 211/22 (2006.01) C07D 211/34 (2006.01) C07D 213/82 (2006.01) C07D 217/04 (2006.01) C07D 217/06 (2006.01) C07D 217/24 (2006.01) C07D 311/22 (2006.01) C07D 319/20 (2006.01) C07D 333/38 (2006.01) C07D 401/12 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01) C07D 417/12 (2006.01) C07D 453/02 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 475/00 (2006.01) C07D 4

Patent

CA 2210682

This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.

Cette invention se rapporte à certains composés bicycliques possédant un noyau constitué de deux cycles hexagonaux fusionnés, par exemple, benzopyrane, isoquinoline, isoquinolone, tétrahydronaphtalène, dihydronaphtalène ou tétralone, remplacés par une fonctionnalité à la fois basique et acide. Ces composés sont utilisés dans l'inhibition de l'agrégation plaquettaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycoprotein iib/iiia antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycoprotein iib/iiia antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein iib/iiia antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1598341

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.